Dr. Annie Mo is a program officer and contracting officer representative (COR III) of the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institute of Health (NIH). She oversees the institute’s extramural vaccine research and development portfolios for parasitic diseases including malaria and neglected tropical diseases. She also serves as a scientific liaison for several trans-divisional research programs, as well as a member of the NIAID Technology Evaluation Advisory Committee, the NIH Program Leadership Committee, and the NIH Staff Training Advisory Committee.
Prior to joining the government, Dr. Mo worked as a senior scientist in Wyeth (now Pfizer) focusing on developing vaccines for paramyxovirus and HSV-2, and then became the director of infectious diseases of a Massachusetts-based biotechnology firm Antigenics Inc. (now Agenus Inc.), supervising multiple R&D programs for a variety of infectious diseases such as genital herpes, tuberculosis, and malaria and a propriety adjuvant QS-21.
Dr. Mo obtained her doctoral degree in viral immunology, and pursued her postdoctoral training in antigen processing and presentation at Dana-Farber Cancer Institute.
Annie X. Mo, PhD Presentations
June 19, 2020 at 12:30 PM - 1:45 PM
The late stage development of vaccines for global health use are challenged by complex and costly clinical studies in low-income settings and unclear financial markets. This session will describe the development strategies and partnerships that support the development of malaria, typhoid, and rotavirus vaccines.